# RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

> **NCT03584464** · NA · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 205 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT03584464
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-14
- **Primary completion:** 2020-11-04
- **Final completion:** 2022-09-28
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03584464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03584464, "RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03584464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*